Search Results 801-810 of 6722 for albumin

1. Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma - Mayo Clinic

   ... albumin > 3.0 g/Dl 8. Willingness and ability to consent (and assent if under age 18) for self to participate in study. Willingness and ability to comply ...

2. An Open-label Study to Investigate the Efficacy, Safety and Tolerability of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy - Mayo Clinic

   The subject has a history of hypersensitivity or allergies to human blood products such as human IgG, albumin, or other blood components. The subject has ...

3. Clinical trials - Oncology (Medical)

   Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

4. Clinical trials - Oncology (Medical)

   Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

5. A Study to Collect Blood DNA Samples from Patients with Clinically Diagnosed Alzheimers Disease, Lewy Body Disease, and Frontotemporal Degeneration - Mayo Clinic

   The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body disease, and ...

6. ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer - Mayo Clinic

   ... albumin ≥3 g/dL). Recovered from all toxicities to Grade 1 or less by NCI CTCAE v4.03 (except alopecia or peripheral neuropathy that may be Grade 2 or less) ...

7. A Study to Understand the Clinical Characteristics and to Identify Gene(s) and/or Protein(s) causing Amyloid Myopathy - Mayo Clinic

   This research is being done to help us better understand the clinical characteristics and to identify gene(s) and/or protein(s) causing these diseases. The ...

8. A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas - Mayo Clinic

   ... Albumin (HSA); Dulbecco Modified Eagle's Medium (DMEM); materials of bovine origin; local anaesthetics or gadolinium (MRI contrast); Known hypersensitivity ...

9. Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer. - Mayo Clinic

   Albumin ≥3.0 g/dL; 8. Acceptable coagulation parameters including international normalized ratio (INR) <1.5 and partial thromboplastin time (PTT) ...

10. Study to Evaluate Chemoembolization Combined with Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma - Mayo Clinic

    Albumin ≥2.8 g/dL;; International normalized ratio ≤1.6;; 2+ proteinuria or less urine dipstick reading;; Calculated creatinine clearance (CL) ≥ 30 mL/min ...